account(Crain?s) ? Hospira Inc. wooed its new CEO away from Allergan Inc., the Southern California maker of Botox, with compensation that will total $12.4 million in his first year. F. Michael Ball, 55, is succeeding Christopher Begley, 58, who has...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to New Hospira CEO Ball to see big payday this year
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account